Epstein-barr Virus Associated Lymphoma
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus Associated Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders [Phase 2]
This Phase 2 clinical trial investigates unrelated cord blood transplantation for Epstein-Barr virus–associated lymphoproliferative diseases…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma
A mechanistic study of the Epstein-Barr virus mRNA vaccine WGc-043 in EBV-positive relapsed/refractory lymphoma; the trial is not yet recrui…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases [Phase 1, Phase 2]
This document provides an update on an early-stage study of EBV-Tscm cytotoxic T cells for Epstein-Barr virus–driven lymphomas and post-tran…